HGPS, Progeria, is only reported prevalence of one in every four to eight million births and is prevalent in thirty-one countries However, according to a recent study, the numbers are leaning more towards every …show more content…
Those with Progeria can also receive occupational and physical therapy to help them keep moving if their joints are particularly stiff. Farnesyltransferase inhibitors (FTIs) are currently used for treating cancer. Scientists have found that these might reverse the nuclear structure abnormalities that are believed to cause progeria. Studies on mice with progeria-like signs suggest that FTIs may offer some improvements. In September 2012, results were released for a first clinical drug trial treatment for children with Progeria, using a farnesyltransferase inhibitor. The findings showed significant improvements in bone structure, weight gain, and the cardiovascular